Item Description:
title
Authorize the expenditure of $8,815,000 for 41 Agmts with providers for prevention, treatment, and other strategies to support the Hennepin County Opioid Framework; supp appr to 2024 Opioid Special Revenue fund
end
Resolution:
body
BE IT RESOLVED, that the County Board authorizes the expenditure of $8,815,000 from Opioid Settlement Funds for strategies: A1, A3, A5, A8, A9, A11, A13, B1, B2, B3, B4, B6, B10, B13, B15, C1, C2, C3, C6, C10, E1, G2, G6, G7, G8, G9, G10, G11, G12, H1, H2, H3, H9, H10, H11, J3, L1, as delineated in Exhibit A of the Amended Minnesota State-Subdivision Agreement; and
BE IT FURTHER RESOLVED, that 41 contracts, outlined in Attachment 1, to provide opioid prevention, response, and treatment services during the period of January 1, 2024 through December 31, 2025 with a total combined not to exceed amount of $8,815,000 be approved, as described in the table below; that the Chair of the Board be authorized to sign the Agreements on behalf of Hennepin County; and the Controller be authorized to disburse funds as directed; and
BE IT FURTHER RESOLVED, that a supplemental appropriation to increase the 2024 revenue and expenditure budget for the Opioids Settlement Special Revenue Fund by $4,407,500 for prevention, response, and treatment services be approved.
end
Background:
Hennepin County filed suit against several opioid manufacturers and distributors several years ago. In 2022, Hennepin County began receiving direct allocations from the National Settlement Agreements with Johnson & Johnson, AmerisourceBergen, Cardinal Health, and McKesson and expected bankruptcy resolutions with Purdue Pharma L.P. and Mallinckrodt plc. ("Opioid Settlement Funds"). In a prior board action (Resolution 22-0404 R1), the County Board authorized the expenditure of $1,604,485 for 18 contract renewals addressing opioid treatment and prevention. In a prior board action (Resolution 23-0395), the County Board authorized the expenditure of...
Click here for full text